DMARD
Showing 1 - 25 of 339
Rheumatoid Arthritis, DMARD-naive and Early Disease Patients Trial in Prague (CR6086, Methotrexate, Placebo)
Completed
- Rheumatoid Arthritis, DMARD-naive and Early Disease Patients
- CR6086
- +2 more
-
Prague, CzechiaInstitute of Rheumatology
Oct 4, 2021
INCMNSZ - Rheumatoid Arthritis Cohort
Recruiting
- Early Rheumatoid Arthritis
- Rheumatoid Arthritis
- DMARD´s and multidisciplinary treatment
-
Mexico City, Tlalpan, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Apr 4, 2022
Herpes Zoster Trial in Hong Kong (recombinant subunit herpes zoster vaccine)
Not yet recruiting
- Herpes Zoster
- recombinant subunit herpes zoster vaccine
-
Hong Kong, ChinaDepartment of Medicine, Tuen Mun Hospital
Dec 18, 2021
Rheumatoid Arthritis Trial in Ubbergen, Amsterdam (Adalimumab trough concentration, Usual care)
Recruiting
- Rheumatoid Arthritis
- Adalimumab trough concentration
- Usual care
-
Ubbergen, Gelderland, Netherlands
- +1 more
Jun 8, 2021
Rheumatoid Arthritis Trial in Omaha (Leflunomide, Methotrexate-Sulfasalazine-Hydroxychloroquine,
Completed
- Rheumatoid Arthritis
- Leflunomide
- +2 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Jan 14, 2021
Rheumatoid Arthritis Trial in United States (procedure, drug, device)
Recruiting
- Rheumatoid Arthritis
- Implant Procedure
- +3 more
-
Birmingham, Alabama
- +33 more
Jan 3, 2023
Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)
Terminated
- Rheumatoid Arthritis
- Methotrexate
- +5 more
-
Pondicherry, IndiaDepartment of Clinical Immunology , Jawaharlal Institute of Post
Jul 25, 2021
Rheumatoid Arthritis Trial in Dhaka (Methotrexate, Tofacitinib)
Unknown status
- Rheumatoid Arthritis
-
Dhaka, BangladeshBangabandhu Seikh Mujib Medical University
Jul 6, 2020
Rheumatoid Arthritis Trial in Worldwide (Non-biological DMARD's, Cimzia, Orencia)
Active, not recruiting
- Rheumatoid Arthritis
- Non-biological DMARD's
- +3 more
-
Aalborg, Denmark
- +29 more
Jul 7, 2022
Psoriatic Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib)
Terminated
- Psoriatic Arthritis
- Filgotinib
- Placebo to match filgotinib
-
Covina, California
- +58 more
Feb 18, 2022
Rheumatoid Arthritis Trial in Chicago (Lab Work, Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of
Completed
- Rheumatoid Arthritis
- Lab Work
- +11 more
-
Chicago, IllinoisOutpatient Care Center
Jul 13, 2020
National Data Bank for Rheumatic Disease Registry Study of
Completed
- Rheumatoid Arthritis
- (no location specified)
Jul 15, 2020
Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
- +15 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 28, 2021
Rheumatoid Arthritis Trial in Norway (TNF inhibitors, Synthetic DMARD(s), Co-medication: Synthetic DMARDs)
Active, not recruiting
- Rheumatoid Arthritis
- TNF inhibitors
- +2 more
-
Bergen, Norway
- +9 more
Sep 14, 2020
The Norwegian Antirheumatic Drug Register
Recruiting
- Inflammatory Joint Diseases
-
Drammen, Buskerud, Norway
- +5 more
Aug 19, 2022
Assess Structural Damage in Rheumatoid Arthritis Using
Completed
- Rheumatoid Arthritis
- Observational study
-
Baltimore, Maryland
- +35 more
Oct 25, 2021
Rheumatoid Arthritis Patients
Completed
- Rheumatoid Arthritis
- Musculoskeletal Ultrasound Imaging
- +3 more
-
Oxford, United KingdomNuffield Orthopaedic Centre
May 19, 2022
Safety of Abatacept Treatment in Denmark Using Danish Database
Active, not recruiting
- Rheumatoid Arthritis (RA)
- Psoriatic Arthritis (PsA)
-
Princeton, New JerseyLocal Institution
Jun 13, 2022
Abatacept in Sweden Using Swedish Rheumatology Quality Register
Active, not recruiting
- Rheumatoid Arthritis
- Psoriatic Arthritis
-
Princeton, New JerseyLocal Institution
Jun 7, 2022
Rheumatoid Arthritis Trial in Abu Dhabi (Anti-TNF, JAK inhibitor)
Not yet recruiting
- Rheumatoid Arthritis
- Anti-TNF
- JAK inhibitor
-
Abu Dhabi, United Arab EmiratesAbu Dhabi Stem Cells Center
May 17, 2022
Rheumatoid Arthritis Trial in Montpellier (Abatacept (M3-M12), TNF Inhibitor (M3-M12), TNF Inhibitor (M0-M3))
Not yet recruiting
- Rheumatoid Arthritis
- Abatacept (M3-M12)
- +2 more
-
Montpellier, FranceCentre Hospitalier Universitaire de Montpellier
Jun 16, 2022
Rheumatoid Arthritis Trial in Leeds (Infliximab, Methylprednisolone, Methotrexate)
Completed
- Rheumatoid Arthritis
- Infliximab
- +3 more
-
Leeds, West Yorkshire, United KingdomChapel Allerton Hospital
Oct 30, 2019
Rheumatoid Arthritis Trial in Strasbourg (Spironolactone, Placebo)
Recruiting
- Rheumatoid Arthritis
- Spironolactone
- Placebo
-
Strasbourg, Alsace, FranceUniversity Hospital, Strasbourg, France
Aug 17, 2022